Practical diabetes internationalBarnett AH. Treatment options for type 2 diabetes: introducing the incretin-based therapies. Pract Diabetes Int 2009; 26: 179-83.Barnett, A. (2009) `Treatment options for type 2 diabetes: introducing the incretin-based therapies', Practical Diabetes International, 26(...
1 There are approximately 57 million people in the United States living with pre-diabetes. Type 2 DM accounts for 90 to 95 percent of all the patients diagnosed with diabetes. It is important to screen patients at risk for type 2 DM due to the gradual incr...
Transforming treatment options for people living with type 2 diabetes Endogenex, in partnership with Mayo Clinic, was founded to revolutionize the therapeutic approach to type 2 diabetes (T2D). Endogenex’s innovations leverage energy delivery in the small intestine (duodenum) to reset the body’s...
When levels of glucose in the blood rise (for example, after a meal), the pancreas produces more insulin.Type 2 diabetes occurs when your body's cells resist the normal effect of insulin, which is to drive glucose in the blood into the inside of the cells. This condition is called ...
Food and Drug Administration for the treatment of type 2 diabetes in youth. Because of recently amended pharmaceutical regulations, however, it is likely that more antidiabetic medications soon will be added to the armamentarium of therapeutic options for youth with type 2 diabetes. Additionally, ...
Insulin allows glucose to move out of the blood into cells throughout the body, where it is used for fuel. People with diabetes mellitus either do not produce enough insulin (type 1 diabetes), cannot use insulin properly (type 2 diabetes), or both (various forms of diabetes). In diabetic...
The gp130 receptor cytokines IL-6 and CNTF improve metabolic homeostasis but have limited therapeutic use for the treatment of type 2 diabetes. Accordingly, we engineered the gp130 ligand IC7Fc, in which one gp130-binding site is removed from IL-6 and replaced with the LIF-receptor-binding ...
It cannot keep up with the demand for more and more insulin. As a result, blood glucose levels rise and stay high.Type 2 diabetes is also called adult-onset diabetes. That's because it almost always used to start in middle or late adulthood. However, more and more children and teens ...
Two recent developments have served to refocus attention on the treatment of type 2 diabetes mellitus. First, the prevalence of the disease is increasing at an alarming rate, including in pediatric populations. Second has been the demonstration that intensive pharmacotherapy of the disease has a dram...
Dulaglutide for the treatment of type 2 diabetes. Dulaglutide ; GLP-1 receptor agonist ; clinical trial ; insulin secretion ; once weekly injection ; therapy ; type 2 diabetes AJ Scheen - 《Expert Opinion on Biological Therapy》 被引量: 15发表: 2017年 DULAGLUTIDE FOR THE TREATMENT OF TYPE 2...